Work

The Impact of New Cardiovascular Device Technology on Health Care Costs

Year: 2011

Type: article

Abstract: Drug-eluting coronary stents (DES) are widely used(1) and entail sizeable Medicare hospital expenditures.(2) However, the overall cost impact of DES has not been well quantified. Clear understanding of how new technologies like DES affect healthcare expenditures can provide insight into national trends in healthcare cost growth, of which new technology is presumably the leading driver.(3) New technology may not only increase costs by being more expensive than previous treatments, but also by changing the patterns of care for chronic disease.(4) Accordingly, we sought to assess the overall impact of DES on Medicare expenditures in a nationally-representative cohort of Medicare beneficiaries with coronary artery disease (CAD).

Source: Archives of Internal Medicine

DOI: 10.1001/archinternmed.2011.141

Author: Peter W. Groeneveld

Institutions: VA Pittsburgh Healthcare System, Leonard Davis Institute of Health Economics, Center for Healthcare Evaluation, Research, and Promotion, University of Pennsylvania

Language: English

Topic: Coronary Interventions and Diagnostics

Subfield: Surgery

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: Agency for Healthcare Research and Quality, National Heart, Lung, and Blood Institute